-+ 0.00%
-+ 0.00%
-+ 0.00%

NASUS PHARMA ANNOUNCES FDA CLEARANCE TO INITIATE CLINICAL STUDY OF NS002 IN THE TREATMENT OF ANAPHYLAXIS

Reuters·09/14/2026 12:00:00

Please log in to view news